Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014;26(6):399-404
It does mean clinicians still rely on overall risk, not LDL alone, when deciding whether medicine is worth the benefit.What is new in 2026 and what is not settledThree recent PubMed-indexed papers point in the same direction: lower LDL earlier may help some people, but the evidence is still evolving
Clinical Evidence: GLP-1 Results vs Vitamin Injection Outcomes Multiple randomized controlled trials comparing GLP-1 medications to lifestyle intervention alone show weight loss ranging from 12-22 pounds over 6 months, depending on starting weight and adherence
Similarly, compounded tirzepatide may include glycine and B12 , niacinamide , or levocarnitine
This work was financially supported by the Yunnan Clinical Research Center for Rheumatism in Traditional Chinese Medicine (202405AJ310004), the Yunnan Science and Technology Talent and Platform Program (202105AG070012), the Yunnan University of Chinese MedicineHospital Joint Fund Projects (XYLH2024042 and XYLH2024030), the Science Research Foundation of Education Department of Yunnan Province (2025Y0638 and 2024Y380), the Expert Workstation of Zhangxuan in Yunnan Province (202305AF150175), the Funding of Yunnan Applied Basic Research Projects-Union Foundation (202401AZ070001-052) and the High level Key Discipline of TCM Construction Project, Rheumatology, of National Administration of Traditional Chinese Medicine (zyyzdxk-2023189)
This was a turning point that led to the next leap: weekly dosing
